Momenta Gets Rivals' Sale Of Generic Lovenox Barred

By Erin Coe · October 28, 2011, 9:51 PM EDT

Massachusetts drugmaker Momenta Pharmaceuticals Inc. on Friday won a preliminary injunction that blocks rivals Watson Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc. and International Medical Systems Ltd. from selling a competing generic version...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Momenta Pharmaceuticals, Inc. et al v. Amphastar Pharmaceuticals, Inc. et al

Case Number

Court

Massachusetts

Nature of Suit

Patent

Date Filed

September 21, 2011

Recent Articles By Erin

September 16, 2024
Teleflex Gets Another Chance In Catheter Patent Feud
March 20, 2024
PTAB To Analyze Moderna COVID Vaccine Patents
December 01, 2023
4 Decisions For Which Justice O'Connor Will Be Remembered
December 01, 2023
Justice O'Connor Shattered Barriers, Built Bridges
September 26, 2020
Judge Amy Coney Barrett: 7th Circ. Decisions To Know
July 17, 2019
'Kindness, Humility, Wisdom': Justices Remember Stevens
July 07, 2019
Despite Progress, Firms Still Slow To Track LGBT Data
June 28, 2019
The Sharpest Dissents Of The Supreme Court Term
April 16, 2019
Riding #MeToo Wave, State Courts Get Their Ships In Order
April 16, 2019
EEOC's Lipnic On Sexual Harassment In The Courthouse